3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow MVC-COV1901: new trials by email Literature Review of MVC-COV1901 trials Research Report on MVC-COV1901
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 in Adults Aged 18 Years and Above MVC-COV1901, AZD1222 - COVID-19 Vaccine | Phase 3 | Completed | Medigen Vaccine Biologics Corp. | 250 | 2022-07-30 | 2023-10-23 |
| A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Vaccine Compared With AZD1222 MVC-COV1901, AZD1222 - COVID-19 Vaccine | Phase 3 | Completed | Medigen Vaccine Biologics Corp. | 200 | 2022-07-09 | 2023-10-23 |
| A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 Against COVID-19 in Adults MVC-COV1901, AZD1222 - Covid19 Vaccine | Phase 3 | Completed | Medigen Vaccine Biologics Corp. | 1030 | 2021-10-08 | 2022-09-30 |
Medigen Vaccine Biologics Corp. (3)
Paraguay (2) · Thailand (1)
Allen Lien, MD. Dr.PH (2) · Luis Francisco Armoa Garcia, MD.Ph.D. (1)